Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,243.00
Bid: 1,244.80
Ask: 1,245.80
Change: 18.80 (1.54%)
Spread: 1.00 (0.08%)
Open: 1,212.40
High: 1,247.00
Low: 1,210.80
Yest. Close: 1,224.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Germany's Merck aims to grow, not sell $1 bln consumer health arm

* Merck KGaA committed to growing over-the-counter division * Dismisses suggestion business might be sold * Unit head says may consider small bolt-on acquisitions By Ben Hirschler LONDON, Nov 28 (Reuters) - Merck KGaA aims to keep hold of its consumer healthcare unit, it s

28 Nov 14 14:13

GlaxoSmithKline fires executive who raised race complaint in South Africa -Bloomberg

Nov 27 (Reuters) - Britain's biggest drugmaker, GlaxoSmithKline Plc, fired an executive from its South African unit for refusing to appear for a performance review, which was called a week after he complained of racial discrimination in the workplace, Bloomberg reported, citing company documents.

28 Nov 14 00:04

MEDIA-Glaxo Fires Executive Who Raised South Africa Race Complaint - Bloomberg

-- Source link: (http://bloom.bg/1uNASrS) -- Note: Reuters has not verified this story and does not vouch for its accuracy

27 Nov 14 22:17

London midday: FTSE flat as energy shares slump ahead of OPEC meeting

Heavy falls in the energy sector kept a lid on gains for the FTSE 100 on Thursday as investors awaited the outcome of a pivotal meeting of the Organization of Petroleum Exporting Countries (OPEC) in Vienna. London's benchmark index was up just 0.06% at 6,733 by midday. The index has traded broadly s

27 Nov 14 11:33

First phase of Ebola vaccine tests successful, GSK says

An Ebola vaccine developed by Glaxosmithkline (GSK) has passed its first phase trial after testing 20 volunteers in the US. The British drugmaker said the vaccine was "well-tolerated" and produced an immunological response in all the volunteers. The vaccine, produced by the National Institutes of H

27 Nov 14 10:21

London open: Investors await pivotal OPEC meeting, Brent drops

The UK stock market opened flat on Thursday as investors awaited a jam-packed day full of economic data, policymaker speeches and a pivotal meeting of the Organization of Petroleum Exporting Countries (OPEC). London's FTSE 100 index was down 0.1% at 6,722 in early deals. While US markets will be cl

27 Nov 14 09:12

London pre-open: All eyes on the OPEC meeting, stocks inch higher

US markets might be closed together for Thanksgiving but those hoping for a quiet day could be disappointed with the Organization of Petroleum Exporting Countries (OPEC) set for a pivotal meeting in Vienna. City sources predict the FTSE 100 will open around eight points higher than yesterday's close

27 Nov 14 07:32

Ebola vaccine from Glaxo passes early safety test

NEW YORK, Nov 26 (Reuters) - An experimental Ebola vaccine made by GlaxoSmithKline caused no serious side effects and produced an immune response in all 20 healthy volunteers who received it in an early-stage clinical trial, scientists reported on Wednesday in the New England Journal of Medicine.

26 Nov 14 22:00

UPDATE 2-Medtronic gets U.S. antitrust OK to buy Covidien with divestiture

(Adds approval of GlaxoSmithKline deals with Novartis) WASHINGTON, Nov 26 (Reuters) - U.S. antitrust regulators on Wednesday approved a pair of major deals in the medical field, including Medtronic's purchase of Covidien, which will allow it to take advantage of tax breaks in Ireland. <p

26 Nov 14 21:01

U.S. approves GSK's purchase of Novartis vaccine business-companies

WASHINGTON, Nov 26 (Reuters) - GlaxoSmithKline won U.S. antitrust approval to buy Novartis AG's vaccine business, with the exception of influenza vaccines, the two companies said on Wednesday. The deal is part of a three-way transaction unveiled in April, which includes Britain's GSK buying

26 Nov 14 19:35

UPDATE 1-Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal -FTC

(Adds background on deal, Novartis statement) WASHINGTON, Nov 26 (Reuters) - Switzerland's Novartis AG has agreed to sell its nicotine patch, Habitrol, in order to win U.S. antitrust approval for a consumer healthcare joint venture with Britain's GlaxoSmithKline, the U.S. Federal Trade Com

26 Nov 14 19:21

Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal -FTC

WASHINGTON, Nov 26 (Reuters) - Novartis AG has agreed to sell its nicotine patch, Habitrol, in order to win U.S. antitrust approval for a consumer healthcare joint venture with Britain's GlaxoSmithKline, the U.S. Federal Trade Commission said on Wednesday. Novartis and GlaxoSmithKline had

26 Nov 14 18:33

BUZZ-AstraZeneca: Pfizer may turn M&A sights on Mylan -Jefferies

** Pfizer can resume its pursuit of AstraZeneca from today as 6-month cooling-off period ends but chances of a fresh bid seen as slim, especially after the U.S. drugmaker's big oncology deal with Merck KGaA last week. ** Jefferies analysts reckon Mylan, which is buying some of Abbott's esta

26 Nov 14 09:01

UPDATE 2-Merck buys rights to NewLink's experimental Ebola vaccine

(Adds terms of deal, details on WHO-coordinated trials; updates share movement) By Ransdell Pierson Nov 24 (Reuters) - Merck & Co Inc on Monday said it would buy worldwide commercial rights to NewLink Genetics Corp's experimental vaccine against the Ebola virus. NewLink, whose

24 Nov 14 16:46

UPDATE 1-Merck buys rights to NewLink's experimental Ebola vaccine

(Adds details on vaccine, Ebola outbreak, share movement) By Ransdell Pierson Nov 24 (Reuters) - Merck & Co Inc on Monday said it would buy worldwide commercial rights to NewLink Genetics Corp's experimental vaccine meant to prevent infection with the Ebola virus. Large late-s

24 Nov 14 15:38

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.